Follow The Filings

ACET Adicet Bio

Adicet Bio earnings company data as of 4:45 AM ET 11/6

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS -1.58 — —
Rev — — —

Insider trades

Open-market buys and sales by ACET's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ACET insider trades
  • $1.6M bought by 1 insider
  • $675K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Ra Capital Management, L.P. 10% owner, +3 joint filers
    Buy
    $1.6M 223,596 shares at $7.17 +23% to stake
    Traded Feb 18–20 Filed Apr 13
  2. Orbimed Advisors LLC 10% owner, +7 joint filers
    Sale
    $675K 104,658 shares at $6.45 100% of stake
    Traded Apr 7–8 Filed Apr 9
  3. Orbimed Advisors LLC 10% owner, +7 joint filers
    Buy
    $5M 5,000,000 shares at $1.00 New stake
    Traded Oct 8, 2025 Filed Oct 10, 2025

Also filed in the last 12 months, not counted as buying or selling: 4 share withholdings for taxes and 1 other transaction.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 7.01,8.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 5.07
10-K/A
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
DEF 14A
DEFA14A
8-K 3.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13D/A —
8-K 2.02,9.01
10-K
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf